EMCN and cancer: This finding aligns with recent evidence supporting a pro-metastatic role for TPM2: for instance, TPM2 can interact with Endomucin to promote proliferation and metastasis in CRC (48), and tumor-associated stromal cells overexpressing TPM2 enhance cancer cell proliferation, migration, and metastatic potential (49).